GB00BDFBVT43
GB00BDFBVT43
OXFORD BIOMEDICA PLC ORD 50P
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 168.741.000 | 128.797.000 | 31.0% |
| Cost of Revenue | 102.761.000 | 75.776.000 | 35.6% |
| Gross Profit | 65.980.000 | 53.021.000 | 24.4% |
| 98.939.000 | 96.523.000 | 2.5% | |
| Operating Income | -32.959.000 | -43.502.000 | 24.2% |
| Pretax Income | -31.936.000 | -47.265.000 | 32.4% |
| Net Income Common Stockholders | -30.128.000 | -43.190.000 | 30.2% |
| -- | -- | -- | |
| -- | -- | -- |